Business · 11/06/2003
FDA Amends Biologics Regulations to Correct Errors and Improve Accuracy
The Food and Drug Administration (FDA) is making changes to its biologics regulations to address errors and enhance the accuracy of the rules, following a request from a committee to review and revise the regulations.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →